Megestrol Acetate
Back to searchMolecule Structure
Scientific Name
Megestrol Acetate
Description of the Drug
Megestrol acetate is a progestin that is administered orally to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00351
http://www.drugbank.ca/drugs/DB00351
Brand Name(s)
Megace, Megace es, Megestrol acetate, Ovaban
Company Owner(s)
Usl Pharma Inc, Teva Pharmaceuticals Usa Inc, Wockhardt Bio Ag, Bristol Myers Squibb, Pharmaceutical Associates Inc, Endo Pharmaceuticals Inc, Twi Pharmaceuticals Inc, Barr Laboratories Inc, Teva Pharmaceuticals Usa, Strides Pharma Global Pte Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL745 | ||
DrugBank | DB00351 | ||
PubChem: Thomson Pharma | 14756125 | 14853785 | |
PubChem | 11683 | ||
LINCS | LSM-2441 | ||
Nikkaji | J6.777F | ||
BindingDB | 50238674 | ||
EPA CompTox Dashboard | DTXSID9040683 | ||
LipidMaps | LMST02030118 | ||
DrugCentral | 1667 | ||
Brenda | 122895 | ||
ChemicalBook | CB9434253 | ||
rxnorm | MEGACE | MEGESTROL ACETATE | MEGESTROL |
KEGG Ligand | C08151 | ||
ChEBI | 6723 | ||
ZINC | ZINC000004097467 |